Bavarian Nordic's mpox vaccine equally effective in teens as adults [Yahoo! Finance]
BAVARIAN NORDIC R/I S/ADR (BVNRY)
NASDAQ:AMEX Investor Relations:
bavarian-nordic.com/investor.aspx
Company Research
Source: Yahoo! Finance
Bavarian Nordic's mpox vaccine induced an antibody response in adolescents equivalent to that of adults. The interim results, presented at the Infectious Diseases Society of America's IDWeek2024 conference in Los Angeles, could provide backing to aid the vaccine's extended use in those under 18 years of age in the US and other areas where mpox cases have occurred. Bavarian Nordic won an European Medicines Agency (EMA) approval for MVA-BN's use in adolescents in September this year, whilst in the US it is still only approved in adults under the brand name Jynneos. During the 2022–2023 mpox outbreak, though, the FDA did grant the vaccine an emergency use authorisation for both pre- and post-exposure use in adolescents. The NIH stated that whilst several countries have approved the vaccine for the prevention of mpox and smallpox in adults, there is “insufficient data available to support licensure for people younger than 18 years,” as per a 16 October press release. The National
Show less
Read more
Impact Snapshot
Event Time:
BVNRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BVNRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BVNRY alerts
High impacting BAVARIAN NORDIC R/I S/ADR news events
Weekly update
A roundup of the hottest topics
BVNRY
News
- US expected to increase biodefence spending under Trump, says vaccine maker Bavarian Nordic [Yahoo! Finance]Yahoo! Finance
- Bavarian Nordic Announces Interim Results for the First Nine Months of 2024 [Yahoo! Finance]Yahoo! Finance
- IDWeek 2024: strategic approaches and challenges in mpox vaccination [Yahoo! Finance]Yahoo! Finance
- Is Bavarian Nordic (BVNRY) Stock Undervalued Right Now? [Yahoo! Finance]Yahoo! Finance
- Bavarian Nordic's mpox vaccine to be trialled in pregnant women and infants [Yahoo! Finance]Yahoo! Finance